Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma

Luca Filippi, Orazio Schillaci, Roberto Cianni, Oreste Bagni

Research output: Contribution to journalArticle

Abstract

Intrahepatic cholangiocarcinoma (ICC) is a severe and rapidly progressive hepatic tumor. Surgery is often impracticable due to locally advanced presentation. On the other hand, chemotherapy has demonstrated only limited effectiveness. For these reasons, liver-directed therapies have been successfully applied for treating ICC. In particular, radioembolization with Yttrium-90 (90Y)-labeled spheres has been reported to be a promising therapeutic approach for this neoplasia. Two commercial forms of 90Y-labeled spheres are available: glass (TheraSphere®) and resin (SIR-Spheres®) microspheres. The aim of the present paper is to review the existing literature on the use of the resin microspheres for the treatment of unresectable and chemorefractory ICC, focusing on the methodology, clinical applications and side effects.

Original languageEnglish
Pages (from-to)809-818
Number of pages10
JournalFuture Oncology
Volume14
Issue number9
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Yttrium
Cholangiocarcinoma
Microspheres
Liver
Glass
Neoplasms
Therapeutics
Drug Therapy

Keywords

  • dosimetry
  • imaging
  • intrahepatic cholangiocarcinoma
  • radioembolization
  • SIR-spheres
  • therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma. / Filippi, Luca; Schillaci, Orazio; Cianni, Roberto; Bagni, Oreste.

In: Future Oncology, Vol. 14, No. 9, 01.04.2018, p. 809-818.

Research output: Contribution to journalArticle

Filippi, Luca ; Schillaci, Orazio ; Cianni, Roberto ; Bagni, Oreste. / Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma. In: Future Oncology. 2018 ; Vol. 14, No. 9. pp. 809-818.
@article{c0a2b1c2610b4763b25a9e49f94736ff,
title = "Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma",
abstract = "Intrahepatic cholangiocarcinoma (ICC) is a severe and rapidly progressive hepatic tumor. Surgery is often impracticable due to locally advanced presentation. On the other hand, chemotherapy has demonstrated only limited effectiveness. For these reasons, liver-directed therapies have been successfully applied for treating ICC. In particular, radioembolization with Yttrium-90 (90Y)-labeled spheres has been reported to be a promising therapeutic approach for this neoplasia. Two commercial forms of 90Y-labeled spheres are available: glass (TheraSphere{\circledR}) and resin (SIR-Spheres{\circledR}) microspheres. The aim of the present paper is to review the existing literature on the use of the resin microspheres for the treatment of unresectable and chemorefractory ICC, focusing on the methodology, clinical applications and side effects.",
keywords = "dosimetry, imaging, intrahepatic cholangiocarcinoma, radioembolization, SIR-spheres, therapy",
author = "Luca Filippi and Orazio Schillaci and Roberto Cianni and Oreste Bagni",
year = "2018",
month = "4",
day = "1",
doi = "10.2217/fon-2017-0443",
language = "English",
volume = "14",
pages = "809--818",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "9",

}

TY - JOUR

T1 - Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma

AU - Filippi, Luca

AU - Schillaci, Orazio

AU - Cianni, Roberto

AU - Bagni, Oreste

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Intrahepatic cholangiocarcinoma (ICC) is a severe and rapidly progressive hepatic tumor. Surgery is often impracticable due to locally advanced presentation. On the other hand, chemotherapy has demonstrated only limited effectiveness. For these reasons, liver-directed therapies have been successfully applied for treating ICC. In particular, radioembolization with Yttrium-90 (90Y)-labeled spheres has been reported to be a promising therapeutic approach for this neoplasia. Two commercial forms of 90Y-labeled spheres are available: glass (TheraSphere®) and resin (SIR-Spheres®) microspheres. The aim of the present paper is to review the existing literature on the use of the resin microspheres for the treatment of unresectable and chemorefractory ICC, focusing on the methodology, clinical applications and side effects.

AB - Intrahepatic cholangiocarcinoma (ICC) is a severe and rapidly progressive hepatic tumor. Surgery is often impracticable due to locally advanced presentation. On the other hand, chemotherapy has demonstrated only limited effectiveness. For these reasons, liver-directed therapies have been successfully applied for treating ICC. In particular, radioembolization with Yttrium-90 (90Y)-labeled spheres has been reported to be a promising therapeutic approach for this neoplasia. Two commercial forms of 90Y-labeled spheres are available: glass (TheraSphere®) and resin (SIR-Spheres®) microspheres. The aim of the present paper is to review the existing literature on the use of the resin microspheres for the treatment of unresectable and chemorefractory ICC, focusing on the methodology, clinical applications and side effects.

KW - dosimetry

KW - imaging

KW - intrahepatic cholangiocarcinoma

KW - radioembolization

KW - SIR-spheres

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=85045452885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045452885&partnerID=8YFLogxK

U2 - 10.2217/fon-2017-0443

DO - 10.2217/fon-2017-0443

M3 - Article

C2 - 29251517

AN - SCOPUS:85045452885

VL - 14

SP - 809

EP - 818

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 9

ER -